Neuron Pathology & Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
- Revenue Growth 4.47%
- Profit Growth 10.30%
- Ebitda 18.49%
- Net Worth 26.23%
- Total Assets -10.41%
About Neuron Pathology & Diagnostics
Neuron Pathology & Diagnostics Private Limited (NPDPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 December 2011 and has a history of 13 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Vivek Goyal and Gopal Singh serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191MH2011PTC224598
-
Company No.
224598
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Dec 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Neuron Pathology & Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Goyal
|
Director | 02-Dec-2011 | Current |
|
Gopal Singh
|
Director | 02-Dec-2011 | Current |
Financial Performance of Neuron Pathology & Diagnostics.
Neuron Pathology & Diagnostics Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.47% increase. The company also saw a substantial improvement in profitability, with a 10.3% increase in profit. The company's net worth Soared by an impressive increase of 26.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuron Pathology & Diagnostics?
In 2019, Neuron Pathology & Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mvg Healthcare Private LimitedVivek Goyal and Gopal Singh are mutual person
-
Mukesh Khanna Foundation
Gopal Singh is a mutual person
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank Thane Ghodbunder Branch : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2015 | Corporation Bank Thane Ghodbunder Branch | ₹2.50 M | Open |
How Many Employees Work at Neuron Pathology & Diagnostics?
Unlock and access historical data on people associated with Neuron Pathology & Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuron Pathology & Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuron Pathology & Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.